Home › Funds › Palmer Knight Co › ELV
Palmer Knight Co position in ELV
ELEVANCE HEALTH INC FORMERLY · Health Care
Palmer Knight Co reported holding 21,963 shares of ELV (ELEVANCE HEALTH INC FORMERLY) in its Q3 2026 13F filing — a position valued at US$8.5M, representing 3.46% of its reported portfolio and ranking #15 among its reported holdings. Palmer Knight Co has disclosed ELV holdings in 11 of the last 11 reported quarters, going back to Q1 2024.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How Palmer Knight Co's ELV position evolved
Palmer Knight Co first disclosed a stake in ELV in Q1 2024 at 10,367 shares (US$5.4M). The position peaked in Q2 2026 at 22,163 shares, worth US$8.6M. Across 11 filings, Palmer Knight Co increased the stake 4 time(s), trimmed it 4 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 21,963 shares valued at US$8.5M — a reduction of -200 shares quarter over quarter.. Notable position changes include a 99% increase in Q4 2025 (shares fell 16% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2024 | 10.37K | $5.38M | New |
| Q2 2024 | 10.46K | $5.67M | Add |
| Q3 2024 | 10.50K | $5.46M | Hold |
| Q4 2024 | 10.72K | $3.95M | Add |
| Q1 2025 | 10.54K | $4.59M | Reduce |
| Q2 2025 | 10.52K | $4.09M | Hold |
| Q3 2025 | 10.27K | $3.32M | Reduce |
| Q4 2025 | 20.43K | $7.16M | Add |
| Q1 2026 | 22.68K | $6.64M | Add |
| Q2 2026 | 22.16K | $8.57M | Reduce |
| Q3 2026 | 21.96K | $8.54M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ELV and 13F data
ELV (ELEVANCE HEALTH INC FORMERLY) is a Health Care company. 23 other funds we track also report a position in ELV — the largest reported positions include Wellington Management Group (US$3.56B), WELLINGTON MANAGEMENT GROUP LLP (US$3.56B), Sanders Capital, LLC (US$2.27B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ELV
- Wellington Management Group 9.21M sh · $3.56B · Q2 2026
- WELLINGTON MANAGEMENT GROUP LLP 9.21M sh · $3.56B · Q2 2026
- Sanders Capital, LLC 5.83M sh · $2.27B · Q3 2026
- Harris Associates (Oakmark) 4.92M sh · $1.90B · Q2 2026
- HARRIS ASSOCIATES L P 4.92M sh · $1.90B · Q2 2026
- First Eagle Investment Management 4.20M sh · $1.63B · Q3 2026
- Artisan Partners Limited Partnership 3.76M sh · $1.46B · Q3 2026
More on Palmer Knight Co
FAQ
How long has Palmer Knight Co held ELV?
Palmer Knight Co has disclosed ELV holdings in 11 of the last 11 reported quarters, going back to Q1 2024.
What is Palmer Knight Co's current position in ELV?
As of Q3 2026, Palmer Knight Co holds 21.96K shares of ELV (ELEVANCE HEALTH INC FORMERLY), valued at $8.54M, representing 3.46% of its reported portfolio and ranking #15.
Has Palmer Knight Co been buying or selling ELV?
In the latest 13F filing (Q3 2026), Palmer Knight Co reduced its position in ELV. The position peaked in Q2 2026 at 22.16K shares.
Which other funds hold ELV?
Other major institutional holders of ELV include Wellington Management Group, WELLINGTON MANAGEMENT GROUP LLP, Sanders Capital, LLC, among 23 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.